Search company, investor...
AdAlta company logo



Other Investors | Alive

About AdAlta

Which is using a platform-technology approach to develop antibody and peptide-based therapeutics against select targets.

Headquarters Location

5959 Cornerstone Court West Suite 100

San Diego, California, 92121,

United States

AdAlta's Product Videos

Compete with AdAlta?

Ensure that your company and products are accurately represented on our platform.

AdAlta's Products & Differentiators


    i-body Fc-fusion protein targeting CXCR4 for fibrotic diseases including IPF; completed Phase I

AdAlta Patents

AdAlta has filed 1 patent.

The 3 most popular patent topics include:

  • Chemokine receptors
  • Clusters of differentiation
  • Cytokines
patents chart

Application Date

Grant Date


Related Topics




Cytokines, Clusters of differentiation, Chemokine receptors, Monoclonal antibodies, Transcription factors


Application Date


Grant Date



Related Topics

Cytokines, Clusters of differentiation, Chemokine receptors, Monoclonal antibodies, Transcription factors



Latest AdAlta News

AdAlta, GPCR Therapeutics partner on new cancer treatment approach

Oct 14, 2022

The companies will assess AdAlta’s CXCR4 inhibiting i-bodies as cancer therapeutics, using GPCR’s combination inhibition technique. AdAlta owns an i-bodies panel that inhibit CXCR4 signalling in different ways. The post AdAlta, GPCR Therapeutics partner on new cancer treatment approach appeared first on Pharmaceutical Business review.

AdAlta Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

AdAlta Rank

AdAlta Frequently Asked Questions (FAQ)

  • Where is AdAlta's headquarters?

    AdAlta's headquarters is located at 5959 Cornerstone Court West, San Diego.

  • What is AdAlta's latest funding round?

    AdAlta's latest funding round is Other Investors.

  • Who are the investors of AdAlta?

    Investors of AdAlta include Bluebox Security.

  • Who are AdAlta's competitors?

    Competitors of AdAlta include Perseus Proteomics, Merus, CoImmune, InhibRx, GANYMED Pharmaceuticals and 12 more.

  • What products does AdAlta offer?

    AdAlta's products include AD-214 and 2 more.

  • Who are AdAlta's customers?

    Customers of AdAlta include GE Healthcare and Carina Biotech.

Compare AdAlta to Competitors


Evogenix aims to provide advanced technologies to provide powerful new antibody therapeutics for world markets.

Femta Pharmaceuticals

Femta is developing a new generation of antibody therapeutics for major disease indications.


Recodgen is developing therapeutics targeting genetic expressions to disease


ModiQuest (CRO) focus is on generation of recombinant monoclonal antibodies (animal, human). The company use antigen specific B-cell selection combined with efficient hybridoma generation or direct antibody cDNA cloning from selected B-cells. MQR offers custom phage display services.

Y's Therapeutics

Y's Therapeutics focuses on developing monoclonal antibody therapies and other molecular-targeted biological drugs for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs. The company also have small molecule compounds in the company's R&D pipeline to diversify the company's portfolio.

CoImmune Logo

CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Using biological components from each patient, the company's immunotherapies employ the patient's dendritic cells to activate an immune response specific to the patient's disease.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.